LakeShore Financial Statements From 2010 to 2025

LakeShore Biopharma Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 1.1 B 1.4 B 366.2 M Slightly volatile Short and Long Term Debt Total 358.5 M 488.1 M 134.4 M Slightly volatile Total Current Liabilities 502.9 M 824.8 M 174.3 M Slightly volatile Total Stockholder Equity 438.7 M 499.8 M 152.1 M Slightly volatile Property Plant And Equipment Net 505.2 M 414.3 M 333.5 M Slightly volatile Current Deferred Revenue 1.7 M 1.8 M 2.1 M Slightly volatile Accounts Payable 53.9 M 49.6 M 28.9 M Slightly volatile Cash 26.7 M 28.1 M 310.4 M Slightly volatile Non Current Assets Total 444.2 M 525.4 M 154 M Slightly volatile Long Term Debt 22.3 M 23.5 M 44 M Slightly volatile Cash And Short Term Investments 201.6 M 221.7 M 333.5 M Slightly volatile Net Receivables 432.9 M 500.9 M 305.1 M Slightly volatile Common Stock Shares Outstanding 61.3 M 36.1 M 39.2 M Slightly volatile Liabilities And Stockholders Equity 944.3 M 1.7 B 382.4 M Slightly volatile Non Current Liabilities Total 41 M 43.2 M 950.2 M Slightly volatile Capital Lease Obligations 434.2 K 457 K 14 M Slightly volatile Inventory 190.2 M 227.6 M 116.8 M Slightly volatile Other Current Assets 75.9 K 79.9 K 11.4 M Slightly volatile Total Liabilities 617.6 M 867.9 M 214.1 M Slightly volatile Property Plant And Equipment Gross 766.2 M 734 M 525.3 M Slightly volatile Total Current Assets 773.4 M 842.2 M 726.3 M Very volatile Capital Stock 18.3 K 28.6 K 11.3 K Slightly volatile Net Working Capital 16.6 M 17.5 M 316.9 M Slightly volatile Short Term Debt 390.9 M 372.3 M 90.2 M Slightly volatile Intangible Assets 61.9 M 72.9 M 80.4 M Slightly volatile Common Stock 31.5 K 30 K 6.7 K Slightly volatile Short and Long Term Debt 279 M 390.4 M 157.7 M Slightly volatile
LakeShore Biopharma Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 37.9 M 48.5 M 31.5 M Slightly volatile Interest Expense 27.1 M 15.7 M 28 M Pretty Stable Selling General Administrative 410.3 M 390.7 M 166.6 M Slightly volatile Selling And Marketing Expenses 211 M 322.5 M 124.7 M Slightly volatile Total Revenue 579.8 M 615 M 361.6 M Slightly volatile Gross Profit 457.6 M 507.2 M 281.9 M Slightly volatile Other Operating Expenses 604.9 M 1.2 B 485.6 M Slightly volatile Research Development 236.2 M 146.4 M 140.8 M Slightly volatile Cost Of Revenue 122.2 M 107.8 M 79.6 M Slightly volatile Total Operating Expenses 556.2 M 659.4 M 392.6 M Slightly volatile Reconciled Depreciation 38.4 M 36.7 M 30.8 M Slightly volatile
LakeShore Biopharma Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 17.8 M 13.6 M 56 M Slightly volatile Begin Period Cash Flow 281.7 M 246.6 M 98.9 M Slightly volatile Depreciation 38.4 M 36.7 M 30.8 M Slightly volatile Capital Expenditures 17 M 17.9 M 99.3 M Pretty Stable End Period Cash Flow 178.5 M 107.5 M 324.9 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 10.68 11.24 52.7839 Slightly volatile PTB Ratio 10.46 11.01 574.7 K Slightly volatile Days Sales Outstanding 304 327 329 Slightly volatile Book Value Per Share 4.2 4.93 1.8841 Slightly volatile Average Payables 51.9 M 66.7 M 57.2 M Slightly volatile Stock Based Compensation To Revenue 0.0187 0.0196 0.2101 Slightly volatile Capex To Depreciation 1.15 1.21 3.4939 Slightly volatile PB Ratio 10.46 11.01 574.7 K Slightly volatile EV To Sales 11.02 11.6 51.8615 Slightly volatile Inventory Turnover 0.78 0.67 0.726 Pretty Stable Days Of Inventory On Hand 418 568 504 Pretty Stable Payables Turnover 3.05 2.0 3.2842 Slightly volatile Sales General And Administrative To Revenue 0.31 0.3 0.4465 Slightly volatile Average Inventory 140.8 M 158.3 M 172.6 M Slightly volatile Research And Ddevelopement To Revenue 0.35 0.48 0.3926 Slightly volatile Capex To Revenue 0.0843 0.0887 0.3385 Slightly volatile Cash Per Share 2.52 2.65 10.1048 Slightly volatile Days Payables Outstanding 120 189 119 Slightly volatile Income Quality 1.2 0.78 1.1988 Slightly volatile Intangibles To Total Assets 0.0514 0.0542 630 Slightly volatile Current Ratio 1.23 1.29 7.2 K Slightly volatile Receivables Turnover 1.09 1.15 1.1269 Slightly volatile Shareholders Equity Per Share 4.2 4.93 1.8841 Slightly volatile Debt To Equity 0.75 0.65 0.4685 Slightly volatile Capex Per Share 0.45 0.48 3.2715 Slightly volatile Average Receivables 308.6 M 347.2 M 378.6 M Slightly volatile Revenue Per Share 11.07 6.17 9.179 Very volatile Interest Debt Per Share 5.05 3.95 2.7862 Slightly volatile Debt To Assets 0.31 0.32 0.231 Slightly volatile Operating Cycle 639 824 823 Slightly volatile Price Book Value Ratio 10.46 11.01 574.7 K Slightly volatile Days Of Payables Outstanding 120 189 119 Slightly volatile Ebt Per Ebit 1.22 1.17 1.2926 Slightly volatile Company Equity Multiplier 2.84 2.97 3.6823 Slightly volatile Long Term Debt To Capitalization 0.16 0.17 0.7586 Slightly volatile Total Debt To Capitalization 0.34 0.38 0.2696 Slightly volatile Debt Equity Ratio 0.75 0.65 0.4685 Slightly volatile Net Income Per E B T 1.12 1.1 1.0806 Slightly volatile Cash Ratio 0.34 0.35 3.8 K Slightly volatile Cash Conversion Cycle 715 811 727 Slightly volatile Days Of Inventory Outstanding 418 568 504 Pretty Stable Days Of Sales Outstanding 304 327 329 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.26 1.32 31.8248 Pretty Stable Price To Book Ratio 10.46 11.01 574.7 K Slightly volatile Fixed Asset Turnover 0.86 1.07 1.0217 Very volatile Debt Ratio 0.31 0.32 0.231 Slightly volatile Price Sales Ratio 10.68 11.24 52.7839 Slightly volatile Asset Turnover 0.41 0.44 1.9 K Slightly volatile Gross Profit Margin 0.62 0.72 0.7578 Slightly volatile Price Fair Value 10.46 11.01 574.7 K Slightly volatile
LakeShore Biopharma Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 7.8 B 6.4 B 8.1 B Slightly volatile Enterprise Value 7.9 B 6.7 B 8.3 B Slightly volatile

About LakeShore Biopharma Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LakeShore Biopharma Co, is a strong investment it is important to analyze LakeShore Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LakeShore Biopharma's future performance. For an informed investment choice regarding LakeShore Stock, refer to the following important reports:

How To Invest In LakeShore Details

Is LakeShore Stock a good investment? Details

What is LakeShore Biopharma's Net Worth? Details

Largest Pharmaceutical Products Companies View

Largest Biotechnology Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details